Mr James Armitage

  • MBBS MD FRCS (Urol)
  • Consultant Urologist

Overview

Clinical interest

  • Kidney Cancer
  • Benign prostate diseases
  • Bladder / kidney stone disease
  • Bladder cancer
  • Prostate cancer
  • Urinary tract infections
  • Urological cancers
  • Laparoscopic and Robotic surgery
  • Laser prostate surgery
  • Pyeloplasty

Publications & affiliations

  1. Aho TF, Armitage JN, Kastner CK. Anatomic Endoscopic Enucleation of the Prostate: the next gold standard? Yes! Andologia. In Press 10.1111/and.13643
  2. Klatte T, Gallagher K, Afferi L, Volpe A, Kroeger N, Ribback S, McNeill A, Riddick AC, Armitage JN, Aho T, Eisen T, Fife K, Bex A, Pantuck AJ, Stewart GD. The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort. BMC Medicine 2019; 17(1): 182
  3. Hsu R, Barclay M, Lyratzopoulos G, Gnanapragasam VJ, Armitage JN. Impact of Hospital Nephrectomy Volume on Intermediate to Long-term Survival in Renal Cell Carcinoma. BJU Int. 2020; 125(1): 56-63
  4. Klatte T, Fife K, Welsh SJ, Sachdeva M, Armitage JN, Aho T, Riddick AC, Matakidou A, Eisen T, Stewart GD. Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting. WJ Urol. 2018; 36(3): 417-425
  5. Armitage JN, Withington J, Fowler S, Finch WJ, Burgess NA, Irving SO, Glass J, Wiseman OJ, on behalf of the BAUS Section of Endourology. PCNL Access by Urologist or Interventional Radiologist: Practice and Outcomes in the United Kingdom. BJU Int. 2017; 119(6): 913-918.

Professional memberships

  1. Fellow of the Royal College of Surgeons (England)
  2. Member of the British Association of Urological Surgeons
  3. British Medical Association
  4. General Medical Council